Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Saito, Takuro, Nishikawa, Hiroyoshi, Wada, Hisashi, Nagano, Yuji, Sugiyama, Daisuke, Atarashi, Koji, Maeda, Yuka, Hamaguchi, Masahide +14 more·2016·Nature Medicine

Cited by (874)

Items 401–500 of 874

  1. CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation
    Shuna Liu, Ziqi Tao, Jianfang Lou, Rong Li, Xin Fu, Juan Xu, Ting Wang, Lei Zhang, Wenwen Shang, Yepeng Mao et al. · 2023 · Journal of Translational Medicine
  2. Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside
    Wook‐Jin Chae, Alfred L.M. Bothwell · 2018 · Frontiers in Immunology
  3. The role of transforming growth factor‐beta in immune suppression and chronic inflammation of squamous cell carcinomas
    Alexander A. Strait, Xiao‐Jing Wang · 2020 · Molecular Carcinogenesis
  4. Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy
    Monika E. Ryba-Stanisławowska · 2024 · Cellular Oncology
  5. Immunotherapy for gastric cancer: Advances and challenges
    Pei Zhang, Chenyan Zhang, Xiaoying Li, Chen Chang, Cailing Gan, Tinghong Ye, Dan Cao · 2024 · MedComm – Oncology
  6. Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
    Aylin Alkan, Tobias Hofving, Eva Angenete, Ulf Yrlid · 2021 · Biomarker Research
  7. Isolation of tumor-infiltrating lymphocytes from preserved human tumor tissue specimens for downstream characterization
    Tamiyo Kobayashi, Shogo Kumagai, Rieko Doi, Elena Afonina, Shohei Koyama, Hiroyoshi Nishikawa · 2022 · STAR Protocols
  8. The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
    Nurul Hakimah Mohd Salim, Ali Mussa, Naveed Ahmed, Suhana Ahmad, Chan Yean Yean, Rosline Hassan, Vuk Uskoković, Rohimah Mohamud, Nur Asyilla Che Jalil · 2023 · Biomedicines
  9. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration
    Xiaomin Chen, Shunfeng Hu, Yang Han, Yiqing Cai, Tiange Lu, Xinting Hu, Yurou Chu, Xiangxiang Zhou, Xin Wang · 2023 · Clinical and Experimental Medicine
  10. Cutibacterium acnes‐derived extracellular vesicles promote tumor growth in renal cell carcinoma
    Kentaro Jingushi, Atsunari Kawashima, Sayaka Tanikawa, Takuro Saito, Akinaru Yamamoto, Toshihiro Uemura, Nesrine Sassi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato et al. · 2024 · Cancer Science
  11. Tumour‐associated changes in intestinal epithelial cells cause local accumulation of KLRG 1+ GATA 3+ regulatory T cells in mice
    Holger Meinicke, Anna Bremser, Maria Brack, Paulina Akéus, Claire F. Pearson, Samuel J. Bullers, Katrin Hoffmeyer, Marc P. Stemmler, Marianne Quiding‐Järbrink, Ana Ízcue · 2017 · Immunology
  12. Evaluating the prognostic significance of tumor-infiltrating lymphocytes in solid tumor: practice of a standardized method from the International Immuno-Oncology Biomarkers Working Group
    Jiu-Yang Liu, Guifang Yang, Fangfang Chen, Chun‐Wei Peng · 2019 · Cancer Management and Research
  13. Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
    Maryam Aftabizadeh, Yijia Li, Qianqian Zhao, Chunyan Zhang, Nigus D. Ambaye, Jieun Song, Toshikage Nagao, Christoph Lahtz, Marwan Fakih, David Kong Ann et al. · 2021 · JCI Insight
  14. Targeting p97–Npl4 interaction inhibits tumor Treg cell development to enhance tumor immunity
    Pingping Nie, Zhifa Cao, Ruixian Yu, Chao Dong, Weihong Zhang, Yan Meng, Hui Zhang, Yu Pan, Zhenzhu Tong, Xiaoya Jiang et al. · 2024 · Nature Immunology
  15. Immunological landscape of colorectal cancer: tumor microenvironment, cellular players and immunotherapeutic opportunities
    Adile Buse Andac-Aktas, Gizem Calibasi‐Kocal · 2025 · Frontiers in Molecular Biosciences
  16. Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules
    Atsunari Kawashima, Takayuki Kanazawa, Kumiko Goto, Mitsunobu Matsumoto, Akiko Morimoto-Okazawa, Kota Iwahori, Takeshi Ujike, Akira Nagahara, Kazutoshi Fujita, Motohide Uemura et al. · 2017 · Cancer Immunology Immunotherapy
  17. The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy
    Shinya Urakawa, Makoto Yamasaki, Tomoki Makino, Yukinori Kurokawa, Kei Yamamoto, Kumiko Goto, Miya Haruna, Michinari Hirata, Akiko Morimoto-Okazawa, Atsunari Kawashima et al. · 2020 · Cancer Immunology Immunotherapy
  18. Immune Microenvironment: New Insight for Familial Adenomatous Polyposis
    Jun Hyeok Yang, Zhengqi Wen, Wenliang Li, Xianghua Sun, Junrui Ma, Xueke She, Hongbin Zhang, Changling Tu, Bing Wang, Depei Huang et al. · 2021 · Frontiers in Oncology
  19. Memory Regulatory T cells Increase Only In Inflammatory Phase of Chronic Hepatitis B Infection and Related to Galectin-9/Tim-3 interaction
    Ching‐Chih Hu, Wen‐Juei Jeng, Yi‐Cheng Chen, Jian‐He Fang, Chien‐Hao Huang, Wei Teng, Yi‐Chung Hsieh, Yung‐Chang Lin, Rong‐Nan Chien, I‐Shyan Sheen et al. · 2017 · Scientific Reports
  20. Non-canonical PD-1 signaling in cancer and its potential implications in clinic
    Haoran Zha, Ying Jiang, Xi Wang, Jin Shang, Ning Wang, Lei Yu, Wei Zhao, Zhihua Li, Xiaochun Zhang, Xiaochun Zhang et al. · 2021 · Journal for ImmunoTherapy of Cancer
  21. The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors
    Huan Tong, He Wei, Alhaji Osman Smith, Juan Huang · 2022 · Frontiers in Immunology
  22. Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target
    Mengnan Liu, Mengting Yang, Yue Qi, Yuting Ma, Qulian Guo, Ling Guo, Chunyan Liu, Wenjun Liu, Lan Xiao, You Yang · 2025 · Frontiers in Immunology
  23. Multiparametric analysis of colorectal cancer immune responses
    Julia K. H. Leman, Sarah Sandford, Janet L Rhodes, Roslyn A. Kemp · 2018 · World Journal of Gastroenterology
  24. Moderating hypoxia and promoting immunogenic photodynamic therapy by HER-2 nanobody conjugate nanoparticles for ovarian cancer treatment
    Qing Zhang, Li‐An Wu, Shaozheng Liu, Qingjie Chen, Lingpeng Zeng, Xuezhong Chen, Qing Zhang · 2021 · Nanotechnology
  25. Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)
    Hongtao Duan, Changjian Shao, Zhilin Luo, Tianhu Wang, Liping Tong, Honggang Liu, Xin Yao, Jie Lei, Jinbo Zhao, Yuan Gao et al. · 2024 · Signal Transduction and Targeted Therapy
  26. High CCR4 expression in the tumor microenvironment is a poor prognostic indicator in lung adenocarcinoma
    Takahiro Karasaki, Guangliang Qiang, Masaki Anraku, Yanbin Sun, Aya Shinozaki‐Ushiku, Eiichi Sato, Kosuke Kashiwabara, Kazuhiro Nagayama, Jun‐ichi Nitadori, Masaaki Sato et al. · 2018 · Journal of Thoracic Disease
  27. Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice
    Louis Szeponik, Paulina Akéus, William Carl Ivar Rodin, Sukanya Raghavan, Marianne Quiding‐Järbrink · 2020 · Cancer Immunology Immunotherapy
  28. Bone Morphogenic Proteins Are Immunoregulatory Cytokines Controlling FOXP3+ Treg Cells
    Lauren M. Browning, Caroline Miller, Michal Kuczma, Maciej Pietrzak, Yu Jing, Grzegorz A. Rempała, Pawel J. Muranski, Leszek Ignatowicz, Piotr Jan Kraj · 2020 · Cell Reports
  29. PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer
    Peiwen Fan, Xi Li, Yaning Feng, Hongchao Cai, Danning Dong, Yanchun Peng, Xuan Yao, Yuping Guo, Miaomiao Ma, Tao Dong et al. · 2021 · Frontiers in Oncology
  30. Tertiary lymphoid structures in colorectal cancer
    Jianyu Lv, Xiuyu Zhang, Mi Zhou, Junbin Yan, Guanqun Chao, Shuo Zhang · 2024 · Annals of Medicine
  31. Nutrient acquisition of gut microbiota: Implications for tumor immunity
    Yusha Wang, Jing Huang, Huan Tong, Yuting Jiang, Jiang Yu, Xuelei Ma · 2025 · Seminars in Cancer Biology
  32. Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment
    Masayuki Shirasawa, Tatsuya Yoshida, Hidehito Horinouchi, Shigehisa Kitano, Sayaka Arakawa, Yuji Matsumoto, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Shintaro Kanda et al. · 2020 · British Journal of Cancer
  33. Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer
    Francesco Sclafani, Claudia Corrò, Thibaud Koessler · 2021 · Cancers
  34. Tissue adaptation of CD4 T lymphocytes in homeostasis and cancer
    Marina V. A. Pereira, Rômulo Gonçalves Agostinho Galvani, Triciana Gonçalves-Silva, Zilton Farias Meira de Vasconcelos, Adriana Cesar Bonomo · 2024 · Frontiers in Immunology
  35. Novel risk stratification of de novo diffuse large B cell lymphoma based on tumour-infiltrating T lymphocytes evaluated by flow cytometry
    Zihang Chen, Xueqin Deng, Yunxia Ye, Limin Gao, Wenyan Zhang, Weiping Liu, Sha Zhao · 2018 · Annals of Hematology
  36. Cell-mediated immune resistance in cancer
    Yuhao Wang, Emily Hays, Martina Rama, Benjamin Bonavida · 2019 · Cancer Drug Resistance
  37. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway
    Feng Chi, Long Chen, Xiaoming Jin, Guijin He, Zhen Liu, Sijia Han · 2022 · Experimental Cell Research
  38. The Prognostic Value of FoxP3+ Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+ Cytotoxic T Cell Density
    Sören Schnellhardt, Johannes Hirneth, Maike J. Büttner-Herold, Christoph Daniel, Marlen Haderlein, Arndt Hartmann, Rainer Fietkau, Luitpold Valentin Distel · 2022 · Frontiers in Immunology
  39. The role of Treg cells in colorectal cancer and the immunotherapy targeting Treg cells
    Hanqing Yu, Ruiliang Yang, Meixiang Li, Dan Li, Yuanqing Xu · 2025 · Frontiers in Immunology
  40. An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis
    Yamei Zhao, Chao Chen, Xiaoming Xu, Xiaoxu Ge, Kefeng Ding, Shu Sen Zheng, Jian Wang, Lifeng Sun · 2021 · OncoImmunology
  41. STAT6 Is Critical for the Induction of Regulatory T Cells In Vivo Controlling the Initial Steps of Colitis-Associated Cancer
    Yael G. Delgado-Ramirez, Angel Ocaña-Soriano, Yadira Ledesma‐Soto, Jonadab E. Olguín, Joselín Hernández-Ruiz, Luis Ignacio Terrazas, Sonia León‐Cabrera · 2021 · International Journal of Molecular Sciences
  42. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characterization in ovarian cancer
    Jingjing Zhang, Miao Lu, Haoya Xu, Fang Ren, Liancheng Zhu · 2022 · Cancer Cell International
  43. STAT6 controls the stability and suppressive function of regulatory T cells
    Ruben Dario Arroyo-Olarte, Ana C. Rivera-Rugeles, Eduardo Nava‐Lira, Cuauhtémoc Ángel Sánchez-Barrera, Yadira Ledesma‐Soto, Rafael Saavedra, Leonel Armas‐López, Luis Ignacio Terrazas, Federico Ávila‐Moreno, Sonia León‐Cabrera · 2023 · European Journal of Immunology
  44. Immune escape of colorectal tumours via local LRH ‐1/Cyp11b1‐mediated synthesis of immunosuppressive glucocorticoids
    Asma Sirageldin Ahmed, Cindy Reinhold, Eileen Breunig, Truong San Phan, Lea Dietrich, Feodora Ivanova Kostadinova, Corinne Urwyler-Rösselet, Verena M. Merk, Mario Noti, Israel Toja da Silva et al. · 2023 · Molecular Oncology
  45. Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
    Lu Chen, Yuchen Wang, Qingqing Hu, Yuxi Liu, Xuchen Qi, Zhihua Tang, Haihong Hu, Nengming Lin, Su Zeng, Lushan Yu · 2023 · Frontiers in Immunology
  46. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer
    Hehuan Zhu, Jessica P Roelands, Eiman I. Ahmed, Imke Stouten, Rachel Hoorntje, Ronald L. P. van Vlierberghe, Marieke E. Ijsselsteijn, Xin Lei, Noel F.C.C. de Miranda, Rob A.�E.�M. Tollenaar et al. · 2024 · Frontiers in Immunology
  47. Immunosenescence in digestive system cancers: Mechanisms, research advances, and therapeutic strategies
    Junyan Zhang, Xiaojiao Guan, Xinwen Zhong · 2024 · Seminars in Cancer Biology
  48. Prognostic roles for IL ‐2‐producing and CD 69+ T cell subsets in colorectal cancer patients
    Edward S. Taylor, John L McCall, Shirley Shen, Adam Girardin, Fran M. Munro, Michael A. Black, Kirsten A. Ward‐Hartstonge, Roslyn A. Kemp · 2018 · International Journal of Cancer
  49. Role of T-Helper 9 Cells in Chronic Hepatitis C-Infected Patients
    Mohamed E. Ali, Omnia El‐Badawy, Noha A. Afifi, Abeer Sharaf Eldin, Elham Ahmed Hassan, Hamada Mohamed Halby, Mohamed A. El‐Mokhtar · 2018 · Viruses
  50. Reprogramming lymphocytes for the treatment of melanoma: From biology to therapy
    Naama Margolis, Ettai Markovits, Gal Markel · 2019 · Advanced Drug Delivery Reviews
  51. Patrolling monocytes inhibit osteosarcoma metastasis to the lung
    Ting Chen, Lin Zhao · 2020 · Aging
  52. Immunometabolism of regulatory T cells in cancer
    Mario Galgani, Sara Bruzzaniti, Claudia La Rocca, Teresa Micillo, Paola de Candia, Maurizio Bifulco, Giuseppe Matarese · 2020 · Molecular Aspects of Medicine
  53. Effective Predictor of Colorectal Cancer Survival Based on Exclusive Expression Pattern Among Different Immune Cell Infiltration
    Xiaowen Xu, Jun Ma, Guanyu Yu, Qun Qiu, Wei Zhang, Fuao Cao · 2021 · Journal of Histochemistry & Cytochemistry
  54. Biomarkers of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer: Beyond PD-L1
    Luis Cabezón‐Gutiérrez, Sara Custodio‐Cabello, Magda Palka-Kotlowska, Soledad Alonso Viteri, Parham Khosravi‐Shahi · 2021 · Clinical Lung Cancer
  55. Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy
    Hiroshi Miyakita, Sotaro Sadahiro, Toshiyuki Suzuki, Lin Fung Chan, Takashi Ogimi, Kazutake Okada, Seiichiro Yamamoto, Hiroshi Kajiwara · 2020 · Oncology
  56. Tumor-Infiltrating PD-1+ Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
    Yusuke Kitagawa, Takashi Akiyoshi, Noriko Yamamoto, Toshiki Mukai, Yukiharu Hiyoshi, Tomohiro Yamaguchi, Toshiya Nagasaki, Yosuke Fukunaga, Toru Hirota, Tetsuo Noda et al. · 2022 · Clinical Colorectal Cancer
  57. Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients
    Zhiyong Li, Yang Liu, Huijie Yi, Ting Cai, Yunwei Wei · 2022 · Frontiers in Genetics
  58. Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer
    Yan Gao, Yulai Zhou, Wei Le, Ziyang Feng, Yihong Chen, Ping Liu, Yinghui Peng, Qiaoqiao Huang, Le Gao, Yongting Liu et al. · 2022 · Frontiers in Immunology
  59. Tumor-infiltrating immune cells and survival in head and neck squamous cell carcinoma: a retrospective computational study
    Lei Zhang, Weiquan Wang, Junhong Chen, Jia Feng, Ya-Zhou Liao, You Feng Zou, Rong Liu · 2024 · Scientific Reports
  60. Lymphatic endothelial cell-mediated accumulation of CD177 + Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma
    Min Ma, Liang Li, Shu-Han Yang, Chuan Huang, Weitao Zhuang, Shujie Huang, Xin Xia, Yong Tang, Zijun Li, Zhi-Bin Zhao et al. · 2024 · OncoImmunology
  61. Sishen Pill and its active phytochemicals in treating inflammatory bowel disease and colon cancer: an overview
    Boxun Zhang, Yingying Cheng, Qin Jian, Sirui Xiang, Qi Xu, Chuchu Wang, Chuan Yang, Junzhi Lin, Chuansheng Zheng · 2024 · Frontiers in Pharmacology
  62. Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients
    Tao Fu, Yanliang Liu, Kai Li, Weiwei Wan, Emmanouil P. Pappou, Christine A. Iacobuzio–Donahue, Zachary J. Kerner, Stephen B. Baylin, Christopher Lee Wolfgang, Nita Ahuja · 2016 · Oncotarget
  63. Relationship Between Intestinal Microorganisms and T Lymphocytes In Colorectal Cancer
    Shuwen Han, Yang Xi, Qi Quan, Yuefen Pan, Miao Da, Qing Zhou · 2019 · Future Oncology
  64. Tumour‐immune microenvironment in duodenal‐type follicular lymphoma
    Hiroaki Inoue, Shinya Rai, Hirokazu Tanaka, Jorge Luis Espinoza, Yosaku Watatani, Takahiro Kumode, Kentaro Serizawa, Shoko Nakayama, Yasuhiro Taniguchi, Yasuyoshi Morita et al. · 2020 · British Journal of Haematology
  65. Copy number variation analysis of m6A regulators identified METTL3 as a prognostic and immune‐related biomarker in bladder cancer
    Xiaoshuai Wang, Jingwei Yu, Jinbao Chen, Yingdong Hou, ZeFeng Du, Haoyang Huang, Siqi Tang, Yueyin Han, Changhai Ding, Zhicheng Xue · 2021 · Cancer Medicine
  66. FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation
    Okan Gultekin, Jordi Gonzalez‐Molina, Elin Hardell, Lidia Moyano‐Galceran, Nicholas Mitsios, Jan Mulder, Georgia Kokaraki, Anders Isaksson, Dhifaf Sarhan, Kaisa Lehti et al. · 2021 · npj Precision Oncology
  67. Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients
    Kentaro Jingushi, Atsunari Kawashima, Takuro Saito, Takayuki Kanazawa, Daisuke Motooka, Tomonori Kimura, Masashi Mita, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi et al. · 2022 · Cancer Immunology Immunotherapy
  68. Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients
    Mohammad A. Al-Mterin, Khaled Murshed, Alhasan Alsalman, Ala Abu-Dayeh, Eyad Elkord · 2022 · BMC Cancer
  69. CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
    Qingda Meng, Davide Valentini, Martin Rao, Ernest Dodoo, Markus J. Maeurer · 2018 · Scientific Reports
  70. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression
    Zijiang Yang, Aiqin Gao, Wenjing Shi, Jingnan Wang, Xianchao Zhang, Zhengyan Xu, Tingting Xu, Yan Zheng, Yuping Sun, Fei Yang · 2021 · OncoTargets and Therapy
  71. Opposing functions of distinct regulatory T cell subsets in colorectal cancer
    Xiao Huang, Dan Feng, Sneha Mitra, Emma S. Andretta, Nima Hooshdaran, Aazam P. Ghelani, Eric Y. Wang, Joe N. Frost, Victoria R. Lawless, Aparna Vancheswaran et al. · 2025 · Immunity
  72. A nomogram‑based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer
    Lingxiong Wang, Nijia Chang, Liangliang Wu, Jinfeng Li, Lijun Zhang, Yin Chen, Zhou Zhou, Jianqing Hao, Qiong Wang, Shunchang Jiao · 2021 · Molecular and Clinical Oncology
  73. The Effect of Intratumoral Interrelation among FOXP3+ Regulatory T Cells on Treatment Response and Survival in Triple-Negative Breast Cancer
    Noriko Goda, Chika Nakashima, Ichiro Nagamine, Sunao Otagaki · 2022 · Cancers
  74. ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis
    Lei Wu, Shengnan Sun, Fei Qu, Xiuxiu Liu, Meili Sun, Ying Pan, Yan Zheng, Guohai Su · 2022 · Frontiers in Immunology
  75. Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours
    Lindsay K. Dickerson, Jason A. Carter, Karan Kohli, Venu Gopal Pillarisetty · 2023 · Gut
  76. Inter-patient and Intra-tumor Heterogeneity in the Sensitivity to Tumor-targeted Immunity in Colorectal Cancer
    Tsubasa Miyauchi, Tomonori Yaguchi, Yutaka Kawakami · 2017 · Japanese Journal of Clinical Immunology
  77. GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells
    Yannick Sebastiaan Rakké, Lucia Campos Carrascosa, Adriaan A. van Beek, Valeska de Ruiter, Rachelle S. van Gemerden, Michail Doukas, Pascal Gabriël Doornebosch, Maarten Vermaas, Susan ter Borg, Erwin van der Harst et al. · 2022 · Cellular and Molecular Gastroenterology and Hepatology
  78. Predictive biomarkers in the era of immunotherapy for gastric cancer: current achievements and future perspectives
    Fujing Sun, Xiaozhuo Gao, Wentao Wang, Xiaoyan Zhao, Jingdong Zhang, Yanmei Zhu · 2025 · Frontiers in Immunology
  79. Colorectal cancer: the immune microenvironment and the gut microbiota – new perspectives, challenges, and opportunities
    Ping Zhou, Wangzheqi Zhang, Yan Liao, Zhiyong Zhai, Sicun Lu, Shuya Jiang, Wei Hu, Wei Gong · 2025 · International Journal of Surgery
  80. Prostaglandin E 2 -EP2/EP4 signaling induces the tumor-infiltrating Treg phenotype for tumor growth
    Ryuma Matsuura, Siwakorn Punyawatthananukool, Ryoji Kawakami, Norihisa Mikami, Shimon Sakaguchi, Shuh Narumiya · 2025 · Proceedings of the National Academy of Sciences
  81. A Newly Defined Pyroptosis-Related Gene Signature for the Prognosis of Bladder Cancer
    Weikang Chen, Wenhao Zhang, Tao You Zhou, Jian Cai, Zhixian Yu, Zhigang Wu · 2021 · International Journal of General Medicine
  82. Type I and II interferon signaling in colorectal cancer liver metastasis
    Bernadette Mödl, Stefan Moritsch, Daniela Zwolanek, Robert Eferl · 2022 · Cytokine
  83. Exploring Immune Cell Diversity in the Lacrimal Glands of Healthy Mice: A Single-Cell RNA-Sequencing Atlas
    Qiwei Fan, Ruyu Yan, Yan Li, Liyuan Lu, Jiangman Liu, Senmao Li, Ting Fu, Yunxia Xue, Jun Liu, Zhijie Li · 2024 · International Journal of Molecular Sciences
  84. In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications
    Yoshinori Hayashi, Azumi Ueyama, Soichiro Funaki, Koichi Jinushi, Naoko Higuchi, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Takuro Saito, Atsunari Kawashima et al. · 2024 · BMC Cancer
  85. The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design
    Matthieu Besneux, Alexander Greenshields‐Watson, Martin J. Scurr, Bruce J. MacLachlan, Adam D. Christian, Michael M. Davies, Rachel Hargest, Simon M. Phillips, Andrew J Godkin, Awen Gallimore · 2018 · Cancer Immunology Immunotherapy
  86. Model-based cell clustering and population tracking for time-series flow cytometry data
    Kodai Minoura, Ko Abe, Yuka Maeda, Hiroyoshi Nishikawa, Teppei Shimamura · 2019 · BMC Bioinformatics
  87. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients
    Keisuke Kazama, JUNYA OTAKE, Tetsuta Satoyoshi, Manabu Shiozawa, Nobuhiro Sugano, Sumito Sato, Yosuke Atsumi, Kazuki Kano, Masaaki Murakawa, Yukio Maezawa et al. · 2020 · In Vivo
  88. An immunotherapeutic approach to decipher the role of long non-coding RNAs in cancer progression, resistance and epigenetic regulation of immune cells
    Krishnapriya M. Varier, Hemavathi Dhandapani, Wuling Liu, Jialei Song, Chunlin Wang, Anling Hu, Yaacov Ben‐David, Xiangchun Shen, Yanmei Li, Babu Gajendran · 2021 · Journal of Experimental & Clinical Cancer Research
  89. Tumor immune-gene expression profiles and peripheral immune phenotypes associated with clinical outcomes of locally advanced pancreatic cancer following FOLFIRINOX
    Jaewon Hyung, Hyo Bhin Lee, Hyung‐seung Jin, S Lee, Heon‐Jin Lee, Gyungyub Gong, Tae Jun Song, S S Lee, Dae Wook Hwang, S.C. Kim et al. · 2022 · ESMO Open
  90. Implication of gut microbiome in immunotherapy for colorectal cancer
    Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Georgios Aloizos, Ariadne Tsagarakis, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Athanasios G. Papavassiliou et al. · 2022 · World Journal of Gastrointestinal Oncology
  91. Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid
    Ken Muramatsu, Miao Zheng, Norihiro Yoshimoto, Takamasa Ito, Inkin Ujiie, Hiroaki Iwata, Hiroshi Shimizu, Hideyuki Ujiie · 2020 · Journal of Dermatological Science
  92. Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment
    Zhang, Hongru, Tomar, Vivek S., Li, Jinyang, Basavaraja, Raghavendra, Yan, Fangxue, Gui, Jun, McBrearty, Noreen, Costich, Tara Lee, Beiting, Daniel P., Blanco, M. Andres et al. · 2022 · Cancer Immunology Research
  93. Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response
    Firas Hamdan, Sara Gandolfi, Federica D’Alessio, Yvonne Giannoula, Julia Kolikova, Manlio Fusciello, Elisa Zaghen, Alessandra Napolano, Salvatore Russo, Ozan Izci et al. · 2026 · Nature Communications
  94. Heterogeneity and subtypes of CD4+ regulatory T cells: implications for tumor therapy
    Hanqing Lin, Yuanteng Xu, Chang Lin · 2024 · Frontiers in Immunology
  95. Spatial cell interplay networks of regulatory T cells predict recurrence in patients with operable non-small cell lung cancer
    Siqi Cai, Guanqun Yang, Mengyu Hu, Chaozhuo Li, Liying Yang, Wei Zhang, Jujie Sun, Fenghao Sun, Ligang Xing, Xiaorong Sun · 2024 · Cancer Immunology Immunotherapy
  96. Improving regulatory T cell-based therapy: insights into post-translational modification regulation
    Aiting Wang, Yanwen Wang, Rui Liang, Bin Li, Fan Pan · 2024 · Journal of genetics and genomics/Journal of Genetics and Genomics
  97. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer
    Man-Sheng Zhu, Qixiang Liang, Tao Chen, Qian Kong, Gengtai Ye, Shitong Yu, Xunjun Li, Qinglie He, Hao Liu, Yanfeng Hu et al. · 2021 · Clinical Epigenetics
  98. The characteristics of the immune cell profiles in peripheral blood in cholangiocarcinoma patients
    Akihiko Kida, Eishiro Mizukoshi, Hidenori Kido, Tadashi Toyama, Takeshi Terashima, Kuniaki Arai, Tatsuya Yamashita, Kazumi Fushimi, Taro Yamashita, Yoshio Sakai et al. · 2021 · Hepatology International
  99. Identification and Validation of 17-lncRNA Related to Regulatory T Cell Heterogeneity as a Prognostic Signature for Head and Neck Squamous Cell Carcinoma
    Qi Sun, Yumei Li, Xin Ling Yang, Xinxin Wu, Zhen Liu, Yakui Mou, Xicheng Song · 2021 · Frontiers in Immunology
  100. A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
    Chongchang Zhou, Yiming Shen, Yangli Jin, Zhisen Shen, Dong Ye, Yi Shen, Hongxia Deng · 2022 · Cancer Medicine